Menarini Silicon Biosystems, the division of Italian pharmaceutical group Menarini which specializes in circulating tumor cell (CTC) capture and analysis, has acquired Janssen Diagnostics' Cellsearch, the first CTC system to gain regulatory approval in both the EU and the US and enter the market.
Cellsearch has been on the block for some time, having originally received US FDA clearance in January 2004 as a diagnostic tool for identifying and counting CTCs in a blood...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?